Leonteq Securities AG’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.3K Buy
630
+280
+80% +$19.1K ﹤0.01% 810
2026
Q1
$22.6K Hold
350
﹤0.01% 976
2025
Q4
$23.6K Sell
350
-228
-39% -$15.3K ﹤0.01% 1065
2025
Q3
$42.4K Sell
578
-172
-23% -$11.4K ﹤0.01% 911
2025
Q2
$39K Buy
750
+150
+25% +$8.54K ﹤0.01% 894
2025
Q1
$38.3K Sell
600
-350
-37% -$20.3K ﹤0.01% 871
2024
Q4
$44.9K Buy
950
+100
+12% +$5.13K ﹤0.01% 843
2024
Q3
$48.7K Buy
850
+450
+113% +$25.8K ﹤0.01% 756
2024
Q2
$20.9K Hold
400
﹤0.01% 911
2024
Q1
$16.3K Buy
+400
New +$15K ﹤0.01% 951
2022
Q4
Sell
-6
Closed -$237 1320
2022
Q3
$237 Sell
6
-1,377
-100% -$60.9K ﹤0.01% 1240
2022
Q2
$60.9K Buy
1,383
+1,083
+361% +$46.8K ﹤0.01% 787
2022
Q1
$12K Hold
300
﹤0.01% 1085
2021
Q4
$12.1K Hold
300
﹤0.01% 1140
2021
Q3
$12.2K Buy
+300
New +$12.5K ﹤0.01% 1048

Other funds holding HALO

Leonteq Securities AG's HALO Position: Q2 2026 in Review

Leonteq Securities AG increased its Halozyme (HALO) stake by 80% in Q2 2026, buying an estimated $19.1K and bringing the position to 630 shares worth $49.3K. The position accounts for ﹤0.01% of the portfolio, ranked #810.

Leonteq Securities AG first reported a position in HALO in Q3 2021 and has held it in 15 quarters since. The position peaked at $60.9K in Q2 2022. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Leonteq Securities AG held 630 shares of Halozyme worth $49.3K as of Q2 2026.
  • Leonteq Securities AG bought 280 Halozyme shares in Q2 2026, an estimated $19.1K.
  • Halozyme made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #810 holding.
  • Leonteq Securities AG first reported a position in Halozyme in Q3 2021 and has held it in 15 quarters since.
  • Leonteq Securities AG's Halozyme position peaked at $60.9K in Q2 2022.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.